Trialbee and Acclinate to Host Webinar on the 5 Key Trends Poised to Significantly Improve Clinical Trial Patient Diversity in 2023

Key Takeaways and Learnings Many historically marginalized communities continue to be excluded from clinical trials. Traditional clinical recruitment ...

The past few years have laid bare many disparities in U.S. healthcare.On average, Black Americans live fewer years than white Americans— commonly due ...

There are few people as seemingly healthy as Olympic gold medalists. But when sprinter Tori Bowie died in her home due to complications from childbirt...

From the content of Diversity Action Plans to the nuances of submission, implementation, and monitoring for inclusive and representative research, the...

Though the life sciences industry has committed to improving diversity in clinical trials, there’s still work to be done. Childhood asthma is a case i...

Earlier this year, the U.S. Food and Drug Administration updated its guidance document on collecting race and ethnicity data in clinical trials. The d...

Under 2022’s Food and Drug Omnibus Reform Act, clinical trial sponsors are required tosubmit diversity action plans with pivotal drug studies such as ...

Clinical research requires trust between the patient and the pharmaceutical companies. When that trust has been damaged, patients will avoid participa...

Inclusive clinical research populations are necessary for a successful study, and new laws are beginning to mandate diversity action plans to promote ...